Glaukos Corp (NYSE:GKOS)

$ 127.45 1.18 (0.93%) Market Cap: 7.00 Bil Enterprise Value: 6.83 Bil PE Ratio: 0 PB Ratio: 10.51 GF Score: 64/100

Q2 2024 Glaukos Corp Earnings Call Transcript
Jul 31, 2024

$117.17 (-0.61%)

Earnings
Q1 2024 Glaukos Corp Earnings Call Transcript
May 01, 2024

$98.91 (+3.03%)

Earnings
Q4 2023 Glaukos Corp Earnings Call Transcript
Feb 21, 2024

$92.79 (+0.72%)

Earnings
Glaukos Corp at JPMorgan Healthcare Conference Transcript
Jan 10, 2024
Glaukos Corp to Discuss the FDA Approval of iDose TR Transcript
Dec 14, 2023
Glaukos Corp at Stifel Healthcare Conference Transcript
Nov 14, 2023
Q3 2023 Glaukos Corp Earnings Call Transcript
Nov 01, 2023

$69.43 (+1.80%)

Earnings
Glaukos Corp at Wells Fargo Healthcare Conference Transcript
Sep 06, 2023
Q2 2023 Glaukos Corp Earnings Call Transcript
Aug 02, 2023

$74.72 (-2.58%)

Earnings
Glaukos Corp at William Blair Growth Stock Conference Transcript
Jun 07, 2023
Q1 2023 Glaukos Corp Earnings Call Transcript
May 03, 2023

$46.46 (+2.24%)

Earnings
Glaukos Corp at Citi Healthcare & Medtech Conference Transcript
Mar 01, 2023
Q4 2022 Glaukos Corp Earnings Call Transcript
Feb 22, 2023

$50.43 (+0.42%)

Earnings
Glaukos Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Q3 2022 Glaukos Corp Earnings Call Transcript
Nov 02, 2022

$53.41 (-2.14%)

Earnings
Q2 2022 Glaukos Corp Earnings Call Transcript
Aug 03, 2022

$53.35 (+0.15%)

Earnings
Q1 2022 Glaukos Corp Earnings Call Transcript
May 04, 2022

$47.51 (-1.66%)

Earnings
Q4 2021 Glaukos Corp Earnings Call Transcript
Feb 22, 2022

$49.07 (-1.90%)

Earnings
Glaukos Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Q3 2021 Glaukos Corp Earnings Call Transcript
Nov 04, 2021

$55.01 (+2.90%)

Earnings
Q2 2021 Glaukos Corp Earnings Call Transcript
Aug 05, 2021

$50.96 (+3.66%)

Earnings
Glaukos Corp Annual Shareholders Meeting Transcript
Jun 03, 2021
Q1 2021 Glaukos Corp Earnings Call Transcript
May 05, 2021

$90.44 (-0.37%)

Earnings
Q4 2020 Glaukos Corp Earnings Call Transcript
Feb 25, 2021

$92.11 (-4.48%)

Earnings
Glaukos Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Q3 2020 Glaukos Corp Earnings Call Transcript
Nov 05, 2020

$56.5 (+0.86%)

Earnings
Glaukos Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020
Q2 2020 Glaukos Corp Earnings Call Transcript
Aug 06, 2020

$49.09 (-1.90%)

Earnings
Glaukos Corp Annual Shareholders Meeting Transcript
Jun 03, 2020
Q1 2020 Glaukos Corp Earnings Call Transcript
May 07, 2020

$41.16 (+1.11%)

Earnings
Q4 2019 Glaukos Corp Earnings Call Transcript
Feb 27, 2020

$61.47 (+0.36%)

Earnings
Glaukos Corp at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Q3 2019 Glaukos Corp Earnings Call Transcript
Nov 06, 2019

$62.43 (-3.43%)

Earnings
Q2 2019 Glaukos Corp Earnings Call Transcript
Aug 07, 2019

$73.1 (-4.22%)

Earnings
Glaukos Corp Annual Shareholders Meeting Transcript
May 30, 2019
Glaukos Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 14, 2019
Q1 2019 Glaukos Corp Earnings Call Transcript
May 08, 2019

$73.47

Earnings
Q4 2018 Glaukos Corp Earnings Call Transcript
Feb 27, 2019

$67.86 (+2.08%)

Earnings

Q1 2019 Glaukos Corp Earnings Call Transcript

May 08, 2019 / 08:30PM GMT

Release Date Price: $73.47

Transcript 10-Q8-K

Operator

Welcome to Glaukos Corporation's First Quarter 2019 Financial Results Conference Call. A copy of today's press release issued after the market closed today is available at www.glaukos.com. (Operator Instructions) This call is being recorded and an archived replay will be available online on the Investor Relations section at www.glaukos.com

I will now turn the call over to Chris Lewis, Director of Investor Relations and Corporate Strategy and Development.

Christopher William Lewis

Glaukos Corporation - Director of IR, Corporate Strategy & Development

Thank you, and good afternoon. Joining me today are Glaukos' President and CEO, Tom Burns; CFO, Joe Gilliam; and COO Chris Calcaterra. Following our prepared remarks, we'll open the call to questions. To ensure ample time and opportunity to address everyone's questions, we request that you limit yourself to one question and one follow-up. If you still have additional questions

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.